Traversed 31 nations
Dr Mahmood Fikri, Executive Director for Health Policies at the MoH, said that the worldwide diabetes management awareness initiative by health major Novo Nordisk is aimed at creating awareness on the social, humanitarian and economic consequences of the lifestyle disease.
"The changing diabetes bus had received a total of 260,000 visitors, out of which about 127,000 people made the early diabetes screening in 31 countries all over the globe," he added.
"The first round of the tour in the Gulf region begins in the UAE, with the bus conducting 2,500 free diabetes tests each in the emirates of Sharjah, Dubai and Abu Dhabi," indicated the chairman of the ministry's national diabetes committee.
Bus's UAE itinerary
The bus has been scheduled to station in Sharjah between Nov.6 and 19, in Dubai from Nov.23 to Dec.6, and in Abu Dhabi from Dec.20 to Jan.4," elaborated Dr Fikri.
He noted, "Focusing on social awareness about the early screening for diabetes, the bus will carry out tests for manifold complications due to the diabetes such as visual risks, glycerin levels, body mass and blood pressure."
"However, no tests will be carried out on adolescents under the age of 18 years, according to the contract with the UAE's ethics committee for health researches," he pointed out.
"The MoH will assign five nurses and doctors to work with the diabetes bus and exchange its shifts from 5pm till 11pm in weekdays. The tests will include blood pressure, BMI, HBA1c, waist and hip circumference, cholesterol to diagnose the disease, determine its dangers and complications," Dr Fikri elaborated.
He said, "The visitors will be distributed with educational materials on healthy lifestyle, significance of physical activities, dangers of smoking and other information that would prevent the dangers of diabetes."
“A total of 285 million people worldwide are estimated to have diabetes, many of which are unaware of their condition, which can only be rectified by improving the quality of life for people with diabetes,” revealed Novo Nordisk.
(Pic used for illustrative purpose)